Education

Live from ASH 2024 | Oral Report Features Encouraging Data of Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax in R/R MM, Including a Median PFS Over 9 Months

ROCKVILLE,Md. and SUZHOU,China,Dec. 10,2024-- Ascentage Pharma (6855.HK),a global biopharmaceutical company engaged in discovering,developing,and commercializing therapies to address global unmet med

12-11 Ascentage Pharma

State Grid Kizilsu Kirghiz Autonomous Prefecture Electric Power Supply Company carries out intelligent upgrading of the power grid

ARTUSH,China,Dec. 11,2024-- Recently,the transformer maintenance personnel of the State Grid Kizilsu Kirghiz Autonomous Prefecture Electric Power Supply Company carried out the installation of current

12-11 State Grid Kizilsu Kirghiz Autonomous Prefecture Electric Power Supply Company

Viva Biotech Officially Establishes Boston Branch, Marking Another Milestone in Global Expansion

HONG KONG,Dec. 11,2024-- Recently,Viva Biotech Holdings Group ("Viva Biotech") announced the official establishment of its new branch in Boston,USA. As a global leader in drug research,devel

12-11 Viva Biotech

Infosys Compaz Strengthens Collaboration with StarHub for Next-generation Technology Solutions

Aims to deliver advanced AI,smart city,and workplace transformation technologies for enterprise clients

12-11 Infosys

Malaysia-China International Brand Conference: A Resounding Success in Kuala Lumpur

KUALA LUMPUR,Malaysia,Dec. 6,2024-- On November 28,2024,according to 17PR reports,the Malaysia-China International Brand Conference was successfully held at theShangri-La Hotel in Kuala Lumpur. Markin

12-10 17PR

Caliway Biopharmaceuticals Included in FTSE TWSE Taiwan Eight Industries and Mid-Cap 100 Indices

NEW TAIPEI CITY,Dec. 7,2024-- Caliway Biopharmaceuticals Co.,Ltd. (TWSE-6919) is proud to announce its inclusion in the FTSE TWSE Taiwan Mid-Cap 100 Index and the FTSE TWSE Taiwan Eight Industries In

12-10 Caliway Biopharmaceuticals

U Power and Major Shareholder Chatchaval Jiaravanon Outline Strategic Collaboration for 2025

Third-generation member of Thailand\'s Charoen Pokphand Group and Fortune magazine owner reinforces commitment to U Power\'s innovative EV battery solutions

12-10 U Power limited

LONGi and Raystech Announce Exclusive Strategic Partnership to Transform Australia's Solar Market

XI\'AN,China,Dec. 9,2024-- On November 25,Raystech Group Pty. Ltd. ("Raystech"),one of Australia\'s leading photovoltaic distributors,signed a groundbreaking strategic cooperation agreement

12-10 LONGi

Lunit Marks Go-Live in Groundbreaking National AI Cancer Screening Program in BreastScreen NSW

Lunit INSIGHT MMG integrated into the clinical workflow of Australia\'s BreastScreen New South Wales to assist in reading approximately 31,000 mammography exams annually

12-10 Lunit

IASO Bio Presented Study Findings on the Impact of CAR T-Cell Persistence on Clinical Outcomes in Relapsed/Refractory Multiple Myeloma with Equecabtagene Autoleucel(FUCASO) Myeloma at 2024 ASH

SHANGHAI and NANJING,China and SAN JOSE,Calif.,Dec. 10,2024-- IASO Biotherapeutics ("IASO Bio"),a biopharmaceutical company focused on the discovery,development,manufacturing,and commerciali

12-10 IASO Bio